Clearance Summary
KENDALL HOME RX THERAPEUTIC STOCKING received FDA 510(k) clearance under submission number K925417, sponsored by Kendall Healthcare Products Co. Div.Of Tyco Health. The device was reviewed via the Traditional premarket notification pathway and assigned to the General Hospital review panel. The statutory decision date of record is 1993-06-04.
- Submission: K925417
- Applicant / Sponsor: Kendall Healthcare Products Co. Div.Of Tyco Health
- Clearance pathway: Traditional
- Review panel: General Hospital
- Device class: Class II
- Regulation citation: 21 CFR 880.5780
- Decision date: 1993-06-04
Classification & Regulation
This clearance is catalogued under FDA product code DWL and 21 CFR 880.5780, within the General Hospital review panel as a Class II device.